On 9 April 2010, a new start-up company (Graphenea) was launched as a joint venture of private investors and nanoGUNE. The new company, which is located at the nanoGUNE facilities, has been created with the mission of developing graphene-based process and product technology as well as conducting related research activities. Amaia Zurutuza, coming from Controlled Therapeutics Scotland (CTS) Ltd. in Glasgow, took on 9 April 2010 her new responsabilities as Scientific Director of Graphenea.